Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $21,088 - $23,414
331 New
331 $21,000
Q1 2020

May 08, 2020

SELL
$46.4 - $67.43 $129,920 - $188,804
-2,800 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $137,788 - $179,732
2,800 New
2,800 $180,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Okabena Investment Services Inc Portfolio

Follow Okabena Investment Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Okabena Investment Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Okabena Investment Services Inc with notifications on news.